GLP1R and type 2 diabetes mellitus: Hypothetically, the GLP‐1 RAs may not be suitable for all T2D patients, because the GLP‐1 receptor agonist may be linked to acute kidney injury, predominantly through prerenal acute failure caused by factors, such as drug‐induced nausea, vomiting, and reduced fluid intake.34, 35